NF-κB associated markers of prognosis in early and metastatic triple negative breast cancer.

CCL2 (MCP-1) also showed a trend towards elevated levels in E0771 mice receiving carbo/pax treatment when compared to anti-PD-1-treated mice ( p = 0.0598) and IgG controls ( p = 0.0567) (Fig. 9 B).

also in 53,322 other papers

This finding suggests that both canonical and noncanonical NF-κB signaling is involved in response to anti-PD-1 therapy, and that there may be significant interplay between these two pathways.

also in 13,097 other papers